TEVA's GALZIN PHASE IV WILSON's DISEASE STUDIES TO INCLUDE PEDIATRIC DOSING, MONITORING OF PREGNANT WOMEN; ZINC ACETATE WILL BE AVAILABLE BY END OF MARCH
Executive Summary
Teva's Galzin (zinc acetate) Phase IV studies will include dosing trials in pediatric patients with Wilson's disease. The pediatric populations will include infants, toddlers and adolescents.